Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

This study has been completed.
Cancer International Research Group (CIRG)
Information provided by (Responsible Party):
Sanofi Identifier:
First received: July 11, 2001
Last updated: March 2, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)